LIIC research programs in the area of nitric oxide for cancer therapeutics are unique in France. The team has acquired specific knowledge and expertise in this field in order to develop/find new therapeutic approaches, to characterize new potential biomarkers and to carry out translational research. The team has also acquired a great deal of expertise in analyzing anticancer/antitumoral properties (in vitro, in vivo and ex vivo) of various molecules including standard or innovative chemotherapeutic agents.
